Identification of a novel BET bromodomain inhibitor‐sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers-Reference-Cited by-同舟云学术

Identification of a novel BET bromodomain inhibitor‐sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers

Published:2013-07-04 Issue:8 Volume:5 Page:1180-1195
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Emadali Anouk¹²³,Rousseaux Sophie³⁴,Bruder‐Costa Juliana³⁴,Rome Claire³⁴,Duley Samuel³⁴,Hamaidia Sieme³⁴⁵,Betton Patricia³⁴,Debernardi Alexandra³⁴,Leroux Dominique³⁴⁶,Bernay Benoit¹²³,Kieffer‐Jaquinod Sylvie¹²³,Combes Florence¹²³,Ferri Elena⁷,McKenna Charles E.⁷,Petosa Carlo⁸,Bruley Christophe¹²³,Garin Jérôme¹²³,Ferro Myriam¹²³,Gressin Rémy³⁴⁹,Callanan Mary B.³⁴⁶,Khochbin Saadi³⁴

Affiliation:

1. CEAiRTSVBiologie à Grande EchelleGrenobleFrance

2. INSERM, U1038GrenobleFrance

3. Joseph Fourier UniversityGrenobleFrance

4. INSERM, U823, Institut Albert BonniotGrenobleFrance

5. Pôle rechercheCHU‐GrenobleGrenobleFrance

6. Onco‐Hematology Genetics UnitPlateforme hospitalière de génétique moléculaire des tumeursPôle de biologieCHU‐GrenobleGrenobleFrance

7. Department of ChemistryUniversity of Southern CaliforniaLos AngelesCaliforniaUSA

8. Institut de Biologie Structurale Jean‐Pierre EbelUMR 5075 CEA‐CNRS‐Université de GrenobleGrenobleFrance

9. Department of Clinical HematologyCHU‐GrenobleGrenobleFrance

Publisher

EMBO